Imv Inc (IMV)

1.740
0.000(0.00%)
After Hours
1.730
-0.010(-0.575%)
- Real-time Data
  • Volume:
    967,948
  • Bid/Ask:
    1.720/1.760
  • Day's Range:
    1.700 - 1.800

IMV Overview

Prev. Close
1.74
Day's Range
1.7-1.8
Revenue
310K
Open
1.75
52 wk Range
1.31-5.72
EPS
-
Volume
967,948
Market Cap
117.5M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,698,150
P/E Ratio
-
Beta
-
1-Year Change
-63.75%
Shares Outstanding
82,081,647
Next Earnings Date
11 Aug 2021
What is your sentiment on Imv Inc?
or
Market is currently closed. Voting is open during market hours.

Imv Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellSellStrong Sell
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Sell
SummaryNeutralStrong SellStrong SellStrong SellStrong Sell

Imv Inc Company Profile

Imv Inc Company Profile

Employees
77
Market
Canada

IMV Inc., a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company’s lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck’s Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.